Adcendo vs Excalipoint Therapeutics

Adcendo vs Excalipoint Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adcendo is on 60/100 and Excalipoint Therapeutics on 39/100.

Adcendo logo
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Try Adcendo
Excalipoint TherapeuticsDeveloping next-generation T-cell engager therapies for cancer and autoimmune diseases.

Where each one leads

Adcendo

  • our overall score: 60/100 against 39/100
  • funding raised: $272M against $68.7M

Excalipoint Therapeutics

Leads on none of the measures we hold for both companies.

At a glance

MeasureAdcendoExcalipoint Therapeutics
What it isDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.Developing next-generation T-cell engager therapies for cancer and autoimmune diseases.
CategoryBiotechnology, Pharmaceuticals, Oncology, Drug DiscoveryBiotechnology, Pharmaceuticals, HealthTech, Oncology
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded20172025
HeadquartersCopenhagen, DenmarkShanghai, China
StatusActiveActive

Size, funding and growth

MeasureAdcendoExcalipoint Therapeutics
Employees60Not published
Total funding$272M$68.7M
Latest roundSeries CSeed
LinkedIn followers9,847Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdcendoExcalipoint Therapeutics
StartupHub scoreOur 0-100 rating60/10039/100
Traction58/10039/100
Team70/10060/100
CommunityNot published15/100
Search visibility34/10011/100
Quality68/10045/100
Agent readinessHow well an AI agent can read and act on the siteF (33/100)Not published
Domain ratingLink authority, 0-10028/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdcendoExcalipoint Therapeutics
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksJqueryNot detected
AnalyticsGoogle Analytics 4Not detected

Adcendo vs Excalipoint Therapeutics: common questions

Which is better, Adcendo or Excalipoint Therapeutics?

On our 0-100 score Adcendo rates higher (60/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Adcendo and Excalipoint Therapeutics compare on the numbers?

Adcendo leads on our overall score (60/100 against 39/100), funding raised ($272M against $68.7M).

Read the full Adcendo review and pricing or the Excalipoint Therapeutics review and pricing. You can also browse other Adcendo alternatives we track.